Skip to content

Kevin Tang, 10% owner at Fulcrum Therapeutics, bought FULC on Jul 16, 2026

Data as of Oct 16

▲ BUY$415K116,671 shares at $3.56Kevin Tang 10% ownerFULC Fulcrum Therapeutics, Inc.
Watch FULC
Traded
Jul 16, 2026
Disclosed
Jul 20, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kevin Tang, 10% owner at Fulcrum Therapeutics, bought FULC on Jul 16, 2026TRADEDDISCLOSED
FULCSimilar stocks (XLV — its sector index fund), rebased to FULC's price on the disclosure day
FULC since disclosure
+0.8%
Similar stocks (XLV) since disclosure
+11.0%
XLV — its sector index fund

Change in closing price from Jul 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYKevin Tang 10% ownerFULC Fulcrum Therapeutics, Inc.$179Kdisclosed Jul 20 · filed 3 days after the trade
  2. ▲ BUYTang Capital Management LLC 10% ownerFULC Fulcrum Therapeutics, Inc.$179Kdisclosed Jul 20 · filed 3 days after the trade
  3. ▲ BUYTang Capital Management LLC 10% ownerFULC Fulcrum Therapeutics, Inc.$415Kdisclosed Jul 20 · filed 4 days after the trade

See every trade on FULC →